Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0000899243-21-047850

Options or other derivatives

  • Senior Vice President, Legal acquired 370,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lackey Melinda Senior Vice President, Legal 2021-12-10 Grant or award · Employee Stock Option (Right to Buy) +370,000 370,000 D
Loading xslF345X03/doc4.xml…